AbbVie Inc. (NEO:ABBV)

Canada · Delayed Price · Currency is CAD

31.93

-0.37 (-1.15%)

At close: Dec 5, 2025

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
United States Revenue	45.54B	43.03B	Log In	Log In	Log In	Upgrade
International Revenue	14.10B	13.31B	Log In	Log In	Log In	Upgrade
Revenue (Total)	59.64B	56.33B	Log In	Log In	Log In	Upgrade

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Immunology Revenue	29.07B	26.68B	Log In	Log In	Log In	Upgrade
Neuroscience Revenue	10.32B	9.00B	Log In	Log In	Log In	Upgrade
Oncology Revenue	6.68B	6.56B	Log In	Log In	Log In	Upgrade
Aesthetics Revenue	4.87B	5.18B	Log In	Log In	Log In	Upgrade
Eye Care Revenue	2.18B	2.24B	Log In	Log In	Log In	Upgrade
Women's Health Revenue	-	-	Log In	Log In	Log In	Upgrade
Other Key Products Revenue	3.76B	3.65B	Log In	Log In	Log In	Upgrade
All Other Revenue	2.76B	3.03B	Log In	Log In	Log In	Upgrade
Revenue (Total)	59.64B	56.33B	Log In	Log In	Log In	Upgrade

Updated Sep 30, 2025. Data Source: Fiscal.ai.